Table 6.

Value of CMR findings in clinical decision-making

Parameter	Value
Benefit from CMR for clinical decision-making, n (%)
Yes	17 (74%)
No	6 (26%)
Details of clinical decision-making based on CMR findings, n (%)
Conclusive diagnosis of underlying cardiac disease in so far unclear condition	8 (35%)
Change in previously suspected cardiac diagnosis	3 (13%)
Identification of myocardial scar location for targeted ablation	1 (4%)
Change in cardiac medication	2 (9%)
Targeted genetic analysis based on CMR findings	2 (9%)
Additional cardiac work-up in family members due to CMR findings	2 (9%)
Optimized scheduling of cardiac follow-up studies	7 (30%)
Targeted endomyocardial biopsy based on CMR findings	3 (13%)